It’s hard to argue that any technology company has had a greater impact in the past decade than BioNTech, the
On Monday, a 17-year drought in the world of Alzheimer’s drugs ended with the FDA approval of Biogen’s Aduhlem (aducanumab).
On Monday, the US Food and Drug Administration granted approval to a keenly-watched Alzheimer’s drug, aducanumab, developed by the drugmaker
Automation is extending into every aspect of how organizations get work done, and today comes news of a startup that
In a joint address to Congress last night, President Biden updated the nation on vaccination efforts and outlined his administration’s